Facilitated By

San Antonio Medical Foundation

Synthesis of novel CK II inhibitors

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
Wang, Hua-Yu
Funded by
Curtana Pharmaceuticals Inc
Research Start Date
Status
Active

Basic Research

Collaborative Project
Basic Research
Cancer